Christopher Teshima

Novel scheme for non-invasive gut bioinformation acquisition with a magnetically controlled sampling capsule endoscope

Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases

Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease

Microbial tryptophan catabolites in health and disease

Chronic administration of dietary grape seed extract increases colonic expression of gut tight junction protein occludin and reduces fecal calprotectin: a secondary analysis of healthy Wistar Furth rats

Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer

Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease

Gut microbiome and health: mechanistic insights

Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease

Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update

Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Crohn's disease

Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation

Ulcerative colitis

The intestinal epithelial barrier: a therapeutic target?

Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets

Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation

Optimizing anti-TNF treatments in inflammatory bowel disease

Small bowel video capsule endoscopy: an overview

Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn’s Disease

Ulcerative colitis

Diet and Inflammatory Bowel Disease: Review of Patient-Targeted Recommendations

Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities

Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD

Anti-TNF Therapy in Crohn’s Disease

Photobiomodulation: lasers vs. light emitting diodes?

A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares

Role of the gastrointestinal ecosystem in the development of type 1 diabetes

Iron-Deficiency Anemia

Phototherapy with artificial light suppresses dextran sulfate sodium‐induced colitis in a mouse model

Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti‐TNF therapy

The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease

Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives

Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long‐term follow‐up of a single centre cohort

Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment?

Double balloon enteroscopy and capsule endoscopy for obscure gastrointestinal bleeding: An updated meta‐analysis

Clinical Practice Guidelines for the Use of Video Capsule Endoscopy

Abnormal intestinal permeability in Crohn's disease pathogenesis

The measurement and clinical significance of intestinal permeability

Long-Term Response Rates to Infliximab Therapy for Crohn’s Disease in an Outpatient Cohort